From May 19, 2023 to June 30, 2023, the company has repurchased 125,782 shares, representing 0.09% for $0.98 million. With this, the company has completed the repurchase of 125,782 shares, representing 0.09% for $0.98 million under the buyback announced on May 19, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 USD | -6.95% | -6.33% | -38.38% |
06-12 | Cytek Biosciences to Seek M&A | CI |
06-12 | Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.38% | 738M | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on May 19, 2023.